Cargando…
KRAS mutations are negatively correlated with immunity in colon cancer
The heterogeneity of colon cancer tumors suggests that therapeutics targeting specific molecules may be effective in only a few patients. It is therefore necessary to explore gene mutations in colon cancer. In this study, we obtained colon cancer samples from The Cancer Genome Atlas, and the Interna...
Autores principales: | Fu, Xiaorui, Wang, Xinyi, Duanmu, Jinzhong, Li, Taiyuan, Jiang, Qunguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834984/ https://www.ncbi.nlm.nih.gov/pubmed/33254149 http://dx.doi.org/10.18632/aging.202182 |
Ejemplares similares
-
Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment
por: Wang, Xinyi, et al.
Publicado: (2020) -
A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020) -
Identifying a new microRNA signature as a prognostic biomarker in colon cancer
por: Lv, Yunxia, et al.
Publicado: (2020) -
Construction of an immune-related signature with prognostic value for colon cancer
por: Lv, Yunxia, et al.
Publicado: (2021) -
Analysis of multi-omics differences in left-side and right-side colon cancer
por: Huang, Yanyi, et al.
Publicado: (2021)